Jump to content

LUNG CANCER 101

ALL expert blogs, podcasts webinars and expert events from LUNGevity and our experts will be posted here.

Followers 0

235 topics in this forum

  1. ASCO Highlights: Dr. Socinski on Management of EGFR wild typ

    By Guest NikoleV,
    • 0 replies
    • 683 views

  2. ASCO Lung Cancer Highlights: Dr. Socinski on Maintenance Che

    By Guest LCSC Info,
    • 0 replies
    • 762 views

  3. The Benefit of Expertise: Careful Pathologic Analysis from L

    By Guest LCSC Info,
    • 0 replies
    • 705 views

  4. Promising Immunotherapy Fails in Much Awaited Lung Cancer Tr

    By Guest LCSC Info,
    • 0 replies
    • 770 views

  5. Does Molecular Heterogeneity Explain a “Mixed Response”

    By Guest LCSC Info,
    • 0 replies
    • 955 views

  6. Dr. Stephanie Harman on Palliative Care and Pain Management

    By Guest LCSC Info,
    • 0 replies
    • 755 views

  7. Potential Surgery for Locally Advanced NSCLC: Assessing Loca

    By Guest LCSC Info,
    • 0 replies
    • 687 views

  8. What does the PARAMOUNT Trial Teach Us About Maintenance The

    By Guest LCSC Info,
    • 0 replies
    • 687 views

  9. I was told I have lung cancer, but now it has spread to my l

    By Guest LCSC Info,
    • 0 replies
    • 705 views

  10. How do we assess response to treatments for lung cancer?

    By Guest LCSC Info,
    • 0 replies
    • 703 views

  11. Retreating with an EGFR TKI after Acquired Resistance?

    By Guest LCSC Info,
    • 0 replies
    • 767 views

  12. Acquired Resistance to Oral EGFR Inhibitor Therapy: Should t

    By Guest LCSC Info,
    • 0 replies
    • 776 views

  13. Insights on “Acquired Resistance” to Oral EGFR Inhibitors

    By Guest LCSC Info,
    • 0 replies
    • 744 views

  14. Closing Out the Santa Monica Molecular Markers Program: Two

    By Guest LCSC Info,
    • 0 replies
    • 696 views

  15. Top Anticipated Lung Cancer Presentations at ASCO 2012

    By Guest LCSC Info,
    • 0 replies
    • 972 views

  16. Refining Risk of Recurrence of a Resected NSCLC: The Importa

    By Guest LCSC Info,
    • 0 replies
    • 691 views

  17. Nuances in Which Patients Should Receive Adjuvant Chemothera

    By Guest LCSC Info,
    • 0 replies
    • 679 views

  18. Panel Discussions on Molecular Markers in Advanced Lung Canc

    By Guest LCSC Info,
    • 0 replies
    • 705 views

  19. Doubts Raised About Avastin’s Benefit in Older Patients with

    By Guest LCSC Info,
    • 0 replies
    • 631 views

  20. Initial Presentations from Santa Monica Targeted Therapies

    By Guest LCSC Info,
    • 0 replies
    • 716 views

  21. Combining Systemic Targeted Therapy with Old School Targeted

    By Guest LCSC Info,
    • 0 replies
    • 629 views

  22. Concluding Portions of Dr. Weiss’s “Highlights in Lung Cance

    By Guest LCSC Info,
    • 0 replies
    • 630 views

  23. Could we improve the accuracy of CT screening by adding a bl

    By Guest LCSC Info,
    • 0 replies
    • 650 views

  24. A Potential New Therapy for Cancer-Related Weight Loss

    By Guest LCSC Info,
    • 0 replies
    • 970 views

  25. New Podcasts on Smoking Cessation and Lung Cancer Highlights

    By Guest LCSC Info,
    • 0 replies
    • 569 views
×
×
  • Create New...